Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection
Authors:
Open Access
- 7 January 2020
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 2, 100015
Abstract
No abstract availableKeywords
Funding Information
- Lyme Disease Association
This publication has 30 references indexed in Scilit:
- Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's ChoreaPLOS ONE, 2013
- Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist’s journeyProceedings of the Japan Academy, Series B, 2012
- Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptomsBrain, Behavior, and Immunity, 2010
- Autoimmune‐mediated polyneuropathy triggered by borrelial infection?Muscle & Nerve, 2008
- Antibody-mediated neuronal cell signaling in behavior and movement disordersJournal of Neuroimmunology, 2006
- Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1aJournal of Neuroimmunology, 2006
- Evidence ofBorreliaAutoimmunity-Induced Component of Lyme Carditis and ArthritisJournal of Clinical Microbiology, 2005
- Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissueJournal of Neuroimmunology, 2005
- Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosidesJournal of the Neurological Sciences, 1993
- Cross-Reactivity between Borrelia burgdorferi Flagellin and a Human Axonal 64,000 Molecular Weight ProteinThe Journal of Infectious Diseases, 1993